Page 1 of Clinical Trials for Metastatic Neuroendocrine Tumor, 709 Total Matches
- 1CompletedLast Updated: June 28, 2011Condition(s): Metastatic Neuroendocrine Tumors
- 2CompletedLast Updated: January 13, 2010Condition(s): Neuroendocrine Tumors; Metastatic Neuroendocrine Tumors
- 3CompletedLast Updated: July 7, 2009Condition(s): Neuroendocrine Tumors; Metastases, Neoplasm
- 4CompletedLast Updated: February 6, 2010Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor
- 5CompletedLast Updated: May 5, 2011Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
- 6Active, not recruitingLast Updated: February 6, 2010Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
- 7Active, not recruitingLast Updated: July 23, 2008Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
- 8CompletedLast Updated: December 1, 2010Condition(s): Neuroendocrine Tumors
- 9RecruitingLast Updated: July 15, 2009Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor
- 10Active, not recruitingLast Updated: April 18, 2012Condition(s): PANCREAS; Neuroendocrine
- 11RecruitingLast Updated: January 10, 2012Condition(s): Neuroendocrine Tumor
- 12Active, not recruitingLast Updated: March 19, 2012Condition(s): Advanced/Metastatic Neuroendocrine Tumors
- 13CompletedLast Updated: April 27, 2009Condition(s): Neuroendocrine Tumor
- 14CompletedLast Updated: December 13, 2009Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
- 15Active, not recruitingLast Updated: August 17, 2010Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
- 16Active, not recruitingLast Updated: July 23, 2008Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
- 17Active, not recruitingLast Updated: June 22, 2011Condition(s): Neuroendocrine Tumors
- 18RecruitingLast Updated: March 8, 2012Condition(s): Neuroendocrine Tumors; Carcinoid Tumors
- 19Active, not recruitingPhase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsLast Updated: February 8, 2010Condition(s): Neuroendocrine Tumors
- 20RecruitingLast Updated: July 2, 2010Condition(s): Breast Cancer; Breast Cancer Metastatic Breast Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Metastatic+Neuroendocrine+Tumor
